CIK 0001736243 · <br>Emerging growth company
Acurx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ACXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 917-533-1469
- Business address
- 259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
- Former names
- Acurx Pharmaceuticals, LLC
- 4 Open-market buy President and CEO bought 5,200 shares at $4.80 ($24,960)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy Director bought 12,500 shares at $6.00 ($75,000)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
Page 11 of 13 · 246 filings